Ray Therapeutics Appoints Dr. Peter Francis as Chief Scientific & Medical Officer and Jenny Holt as SVP, Program Portfolio Management

by Business Wire • 2022/09/06 • 0 Comments

SAN FRANCISCO--(BUSINESS WIRE)--Ray Therapeutics Appoints Dr. Peter Francis as Chief Scientific Officer and Jenny Holt as SVP, Program Portfolio Management

← Glaukos Announces More Than 1 Million iStent® Technologies Implanted Worldwide

Global Ophthalmology EMR Software Market to Reach $470.42 Million by 2027 – ResearchAndMarkets.com →

Post navigation